Inactive Instrument
Monto Minerals Ltd Stock Australian S.E.
Stocks
AU000000MOO0
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
||
| - AUD | - |
|
| 06-22 | Pathkey.AI Ltd acquired Chipforge Pte Ltd for AUD 29.41 million. | CI |
| 05-10 | Pathkey.AI appoints Andrew Farnsworth as CEO | RE |
| Market Cap | 81.89M 57.82M 50.11M 46.91M 42.8M 80.54M 5.51B 550M 215M 2.76B 217M 212M 9.21B | P/E 2024 |
-1.36x | P/E 2025 | -3.77x |
|---|---|---|---|---|---|
| Enterprise Value | 81.87M 57.8M 50.09M 46.89M 42.79M 80.52M 5.51B 550M 215M 2.76B 217M 212M 9.21B | EV / Sales 2024 |
9.78x | EV / Sales 2025 | 21.1x |
| Free-Float |
59.45% | Yield 2024 * |
-
| Yield 2025 | - |
| 07-15 | INTURAI SIGNS WITH ASX-LISTED PATHKEY TO ADVANCE DRONE SWARM COMMAND AND CONTROL ON AI EDGE | AQ |
| 22-07-28 | Opyl : Business Update & Appendix 4C | PU |
| 22-04-27 | Opyl : Business Update & Appendix 4C | PU |
| 22-02-27 | Opyl : Appendix 4D & Half Year Results | PU |
| 21-12-14 | Opyl : 2021 Annual Report to shareholders | PU |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Angelone
CTO | Chief Tech/Sci/R&D Officer | - | 1994-01-16 |
| Chief Executive Officer | - | 2026-05-10 | |
Damon Rasheed
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Damon Rasheed
CHM | Chairman | - | 2025-10-20 |
Paul Niardone
BRD | Director/Board Member | - | 2025-10-20 |
Shannon Robinson
CHM | Chairman | - | 2025-11-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.81% | +14.71% | -16.15% | +22.80% | 38.12B | |
| +3.24% | +10.71% | -40.90% | +160.69% | 13.04B | |
| +0.07% | +1.19% | -22.20% | +65.67% | 5.5B | |
| +0.65% | +10.39% | +2.75% | - | 2.53B | |
| -3.06% | -0.49% | - | - | 1.89B | |
| -1.21% | -2.10% | +19.56% | -42.59% | 1.7B | |
| -2.17% | -1.60% | -34.15% | - | 1.06B | |
| +1.74% | +7.11% | +37.35% | +126.70% | 907M | |
| -0.27% | +2.22% | -32.48% | -46.82% | 847M | |
| Average | -0.02% | +90.83% | -10.78% | +47.74% | 7.29B | |
| Weighted average by Cap. | +1.01% | +190.02% | -19.78% | +55.36% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 398K 281K 243K 228K 208K 391K 26.78M 2.67M 1.05M 13.4M 1.05M 1.03M 44.71M | 322K 227K 197K 184K 168K 317K 21.68M 2.16M 847K 10.85M 854K 835K 36.21M |
| Net income | -3.13M -2.21M -1.92M -1.79M -1.64M -3.08M -211M -21.02M -8.24M -106M -8.3M -8.12M -352M | -1.45M -1.02M -886K -829K -757K -1.42M -97.49M -9.72M -3.81M -48.8M -3.84M -3.75M -163M |
| Net Debt | -375K -265K -229K -215K -196K -368K -25.23M -2.52M -986K -12.63M -993K -972K -42.13M | -25.17K -17.77K -15.4K -14.41K -13.15K -24.75K -1.69M -169K -66.22K -848K -66.71K -65.26K -2.83M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
